Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RUSSO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.780
EU - Europa 24.762
AS - Asia 20.949
SA - Sud America 3.321
AF - Africa 607
OC - Oceania 183
Continente sconosciuto - Info sul continente non disponibili 35
Totale 100.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 50.138
SG - Singapore 8.189
RU - Federazione Russa 6.881
CN - Cina 5.169
IT - Italia 4.330
FI - Finlandia 3.030
DE - Germania 2.906
BR - Brasile 2.658
HK - Hong Kong 2.017
VN - Vietnam 1.875
UA - Ucraina 1.412
PL - Polonia 1.294
GB - Regno Unito 1.195
FR - Francia 1.014
IE - Irlanda 806
JP - Giappone 732
SE - Svezia 584
IN - India 504
KR - Corea 499
BD - Bangladesh 394
CA - Canada 318
TR - Turchia 251
AR - Argentina 240
IQ - Iraq 239
NL - Olanda 238
RO - Romania 204
MX - Messico 194
BE - Belgio 187
AT - Austria 186
AU - Australia 171
ES - Italia 127
ZA - Sudafrica 127
PK - Pakistan 115
IR - Iran 114
CI - Costa d'Avorio 102
UZ - Uzbekistan 99
EC - Ecuador 98
MA - Marocco 89
VE - Venezuela 81
MY - Malesia 80
ID - Indonesia 75
PH - Filippine 67
KE - Kenya 64
CO - Colombia 63
EG - Egitto 62
SA - Arabia Saudita 62
AE - Emirati Arabi Uniti 56
CL - Cile 55
CH - Svizzera 53
TN - Tunisia 48
PY - Paraguay 46
CZ - Repubblica Ceca 44
NP - Nepal 42
OM - Oman 42
LB - Libano 39
LT - Lituania 37
AZ - Azerbaigian 36
GR - Grecia 32
IL - Israele 32
KZ - Kazakistan 32
JM - Giamaica 31
UY - Uruguay 31
DZ - Algeria 30
JO - Giordania 30
BG - Bulgaria 29
AL - Albania 26
PE - Perù 26
PT - Portogallo 26
DK - Danimarca 24
TW - Taiwan 24
EU - Europa 22
CR - Costa Rica 20
BO - Bolivia 19
DO - Repubblica Dominicana 19
RS - Serbia 16
BH - Bahrain 15
KG - Kirghizistan 15
ET - Etiopia 14
PS - Palestinian Territory 14
PA - Panama 13
TH - Thailandia 13
SN - Senegal 12
GE - Georgia 11
SY - Repubblica araba siriana 11
TT - Trinidad e Tobago 11
HN - Honduras 10
HU - Ungheria 10
MD - Moldavia 10
BY - Bielorussia 9
MM - Myanmar 9
UG - Uganda 9
XK - ???statistics.table.value.countryCode.XK??? 9
NG - Nigeria 8
NZ - Nuova Zelanda 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
GA - Gabon 7
NO - Norvegia 7
QA - Qatar 7
SK - Slovacchia (Repubblica Slovacca) 7
Totale 100.500
Salva come PNG Salva come JPEG
Città #
Fairfield 6.498
Ashburn 6.320
Singapore 5.125
Woodbridge 3.308
Chandler 2.824
Houston 2.778
Wilmington 2.597
Seattle 2.541
San Jose 2.238
Cambridge 2.126
Ann Arbor 1.950
Hong Kong 1.936
Moscow 1.166
Zgierz 1.091
Council Bluffs 958
Palermo 927
Beijing 843
Dublin 791
Helsinki 776
Medford 775
Jacksonville 697
Los Angeles 690
Tokyo 679
New York 619
Ho Chi Minh City 602
Santa Clara 595
Des Moines 590
Altamura 536
Nanjing 535
Dallas 529
Frankfurt am Main 526
Lauterbourg 509
Princeton 496
The Dalles 496
Hanoi 462
Lawrence 417
San Diego 383
Hefei 368
Dearborn 332
Boardman 283
Chicago 283
Rome 279
Buffalo 268
São Paulo 263
London 247
Ludwigshafen am Rhein 233
Tulsa 224
Munich 208
Phoenix 199
Milan 194
Brussels 182
Orem 178
Shenyang 171
Nanchang 153
Jinan 151
Seoul 148
Changsha 145
Nuremberg 141
Tianjin 137
Warsaw 132
Hebei 127
Atlanta 125
Seongnam 123
Jiaxing 111
Guangzhou 105
Abidjan 102
Columbus 102
Chennai 99
Bremen 94
Denver 94
Amsterdam 90
Falls Church 90
Izmir 88
Da Nang 87
Kitzingen 87
Kumar 87
Montreal 87
San Paolo di Civitate 87
Saint Petersburg 84
Baghdad 81
Brooklyn 80
Venice 80
Zhengzhou 80
Stockholm 79
Johannesburg 77
Ningbo 77
Haiphong 73
Tashkent 71
Toronto 71
Poplar 69
Redwood City 69
Lappeenranta 66
Rio de Janeiro 65
Shanghai 65
Vienna 65
Belo Horizonte 61
Tehran 59
Hangzhou 56
Mumbai 55
Salt Lake City 54
Totale 65.170
Salva come PNG Salva come JPEG
Nome #
S9-Fibronectin, EGF-R, HB-EGF:biomarkers of urothelial damage during intravesical adjuvant therapy? 573
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 407
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 364
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 361
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 349
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 341
EGFR inhibition in NSCLC: New findings…. and opened questions? 336
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 333
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 324
Dietary restriction: could it be considered as speed bump on tumor progression road? 322
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 321
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 319
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 318
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 317
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 316
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 316
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 314
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 312
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 305
Male breast cancer. 302
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 302
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 301
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 301
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 299
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 299
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 298
Anti-endothelin drugs in solid tumors 296
Founder mutations in BRCA1 and BRCA2 genes 295
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 289
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 289
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 288
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 288
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 287
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 286
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 285
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 282
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 281
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 280
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 279
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 279
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 277
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 276
Breast cancer genome-wide association studies: there is strength in numbers 276
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 275
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 274
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells 272
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 271
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 270
Update on capecitabine alone and in combination regimens in colorectal cancer patients 270
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 270
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 269
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 268
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 267
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 267
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 266
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 266
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 266
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 265
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 264
The Clinical Significance of Unknown Sequence Variants in BRCA Genes 264
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 263
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 263
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 263
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 262
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 262
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 261
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 261
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 261
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 259
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 259
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 259
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 259
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 257
Apoptosis: a relevant tool for anticancer therapy. 256
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. 254
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 254
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 253
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies:a meta-analysis(1988-2007) 253
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 253
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 253
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 253
Nintedanib in NSCLC: Evidence to date and place in therapy 253
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 253
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 252
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 252
Targeted Therapies in Hepatocellular Carcinoma 252
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 252
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 251
Ductal lavage: a way of carefully tracing the breast-secreting duct 251
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 250
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 250
Role of S128R polymorphism of E-selectin in colon metastasis formation 250
Emotional expression and coping style in female breast cancer. 249
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 249
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 248
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 248
Liquid Biopsy in Breast Cancer 248
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 247
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 247
Totale 28.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 344.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 344.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.458 0 0 0 0 0 0 0 0 0 0 719 739
2021/20226.708 388 1.381 240 251 292 278 409 357 658 769 615 1.070
2022/20238.818 900 1.694 158 919 931 1.208 494 630 1.322 66 349 147
2023/20243.879 181 517 267 327 276 745 480 323 45 119 55 544
2024/202511.674 218 767 732 880 447 493 989 1.209 781 1.309 1.568 2.281
2025/202636.534 2.969 1.209 2.334 2.941 3.814 5.563 5.298 3.835 3.012 4.184 1.375 0
Totale 103.425